Skip to main content
. Author manuscript; available in PMC: 2024 Feb 15.
Published in final edited form as: Drug Saf. 2020 Feb;43(2):189–191. doi: 10.1007/s40264-019-00883-6

Figure 2.

Figure 2.

Nationally projected rates of emergency department visits for unsupervised buprenorphine-naloxone tablet ingestions by children aged <6 years per 100,000 dispensed buprenorphine-naloxone tablet prescriptions, compared with proportions of tablet prescriptions dispensed in unit-dose packaging, United States, 2008-2017

Estimates of ED visits for pediatric (age <6) buprenorphine-naloxone ingestions were based on 2008–2017 data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project. Estimates of the percentage of buprenorphine-naloxone tablets dispensed in unit-dose packaging were based on data from the IQVIA: National Prescription Audit.